RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.840
+0.190 (11.52%)
At close: Sep 26, 2025, 4:00 PM EDT
1.870
+0.030 (1.61%)
After-hours: Sep 26, 2025, 7:37 PM EDT
RedHill Biopharma Employees
RedHill Biopharma had 35 employees as of December 31, 2024. The number of employees decreased by 18 or -33.96% compared to the previous year.
Employees
35
Change (1Y)
-18
Growth (1Y)
-33.96%
Revenue / Employee
$272,857
Profits / Employee
-$266,086
Market Cap
6.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35 | -18 | -33.96% |
| Dec 31, 2023 | 53 | -60 | -53.10% |
| Dec 31, 2022 | 113 | -88 | -43.78% |
| Dec 31, 2021 | 201 | 19 | 10.44% |
| Dec 31, 2020 | 182 | 27 | 17.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RDHL News
- 23 days ago - RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights - PRNewsWire
- 5 weeks ago - RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win - PRNewsWire
- 5 weeks ago - RedHill Received Talicia® Licensing Payments Totaling $1.1 Million - PRNewsWire
- 2 months ago - RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease - PRNewsWire
- 3 months ago - RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer - PRNewsWire
- 4 months ago - RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - PRNewsWire
- 5 months ago - RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress - PRNewsWire
- 5 months ago - RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107 - PRNewsWire